Prestige Biologics amends annual report to add block tagging to financial statement notes

PUBT · 2d ago
Prestige Biologics amends annual report to add block tagging to financial statement notes
  • Prestige Biologics filed a corrected annual report for FY2026 ended June 30, 2026, dated Sept. 28.
  • The correction applied block-tagging to selected financial statement notes, including company overview, basis of preparation, and key accounting policies.
  • No changes were disclosed to the underlying financial figures, business description, or other substantive report content.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prestige Biologics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260928000204), on September 28, 2026, and is solely responsible for the information contained therein.